← Alle mensen

AM

Alex Martinez-Marti

6 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Neoadjuvant Osimertinib for Resectable EGFR-Mutated Non-Small Cell Lung Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 september 2025

Five-Year Survival Outcomes With Atezolizumab After Chemotherapy in Resected Stage IB-IIIA Non-Small Cell Lung Cancer...

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 juli 2025

Systemische en intracraniële uitkomsten met nivolumab-ipilimumab bij NSCLC-hersenmetastasen: CheckMate 227/9LA

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2023-08

Durvalumab alleen of plus oleclumab/monalizumab na chemoradiatie bij NSCLC: COAST fase II

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 oktober 2022

Adjuvant pembrolizumab versus placebo bij volledig gereseceerd NSCLC: PEARLS/KEYNOTE-091 fase III

The Lancet. Oncology · 2022-10

Adjuvant atezolizumab na adjuvante chemotherapie bij gereseceerd NSCLC: IMpower010 fase III

Lancet (London, England) · 9 oktober 2021